In conclusion, we report that patients with melanoma lymph node metastases with low FOXP3 TIL count and negative tumour cell PD-L1 expression have reduced survival, and that these metastases also have a low CD8 TIL count. This evidence concerns the gene FOXP3 and melanoma.